Our Cases

Compass Lexecon has been involved in many of the largest and most complex antitrust litigation and financial market cases over the past 30 years.

Find a Case

Sorry, your search didn't return any results.

07/15/20

On 14 July 2020, the European Commission cleared the merger between PKN Orlen, the largest oil refiner in Poland, with its smaller counterpart Lotos, to create an integrated oil and gas supplier with a market capitalization of around $14bn. The...

09/18/19

Following a Phase-II investigation, the European Commission (“EC”) cleared the acquisition by E.ON of Innogy's distribution and consumer solutions business as well as certain electricity generation assets of Innogy, subject to conditions. This Transaction is part of an extensive asset...

12/23/18

In December 2018, the European Commission approved the acquisition by which KME acquired MKM after a Phase II investigation. Both parties are suppliers of copper and copper alloy products. Compass Lexecon provided economic advice to MKM, advising mainly on the...

03/22/17

In March 2017, the UK Competition & Markets Authority (CMA) approved the $1.8 billion transaction by which U.S. based firm Diebold acquired German rival Wincor Nixdorf, after a Phase II investigation. Both Diebold and Wincor Nixdorf are producers of hardware...

01/03/17

Compass Lexecon advised Deutsche Börse during the European Commission’s investigation of its proposed merger with the London Stock Exchange Group (LSEG). The proposed merger would have combined the activities of two of the largest financial infrastructure groups in Europe, which...

01/22/16

In January 2016, the UK Competition & Markets Authority (CMA) approved the completed £40 million acquisition by Regus of Avanta Serviced Office Group. Regus thereby acquired the London-based network of 33 serviced offices. The CMA approved the undertakings offered by...

12/20/15

In December 2015, the Hellenic Competition Commission ("HCC") completed its investigation and unanimously concluded that Athenian Brewery, a wholly-owned subsidiary of Heineken NV, had abused its dominant position. It imposed a record fine of €26.7 million on the company. The...

01/21/15

In January 2015, the European Commission cleared the $13 billion (£9.2 billion) transaction between GlaxoSmithKline (GSK) and Novartis, subject to conditions, after a Phase I investigation. The transaction involved (a) the transfer of Novartis' human vaccines to GSK; (b) a...